Peter Karel Maria Verhasselt

Title: Innovations of Peter Karel Maria Verhasselt

Introduction

Peter Karel Maria Verhasselt is a notable inventor based in Herent, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical compositions. With a total of two patents to his name, Verhasselt's work focuses on innovative solutions for treating infectious diseases.

Latest Patents

Verhasselt's latest patents revolve around the Bacterial ATP synthase binding domain. This invention provides an isolated mutant atpE protein, which is crucial for identifying an ATPase binding domain. The invention also encompasses related nucleic acids, vectors, host cells, pharmaceutical compositions, and articles of manufacture. Furthermore, it outlines methods for determining whether a test compound interacts with the atpE protein, specifically with the ATPase binding domain. The pharmaceutical compositions derived from this invention are particularly aimed at antimicrobials, with a focus on treating tuberculosis in subjects.

Career Highlights

Peter Karel Maria Verhasselt is currently associated with Janssen Pharmaceutica NV, a leading company in the pharmaceutical industry. His work at Janssen has allowed him to contribute to groundbreaking research and development in the field of medicine.

Collaborations

Throughout his career, Verhasselt has collaborated with esteemed colleagues, including Koenraad Jozef Lodewijk Marcel Andries and Jean-Marc Edmond Fernand Marie Neefs. These collaborations have further enhanced the impact of his inventions and research.

Conclusion

Peter Karel Maria Verhasselt is a distinguished inventor whose work in biotechnology has the potential to revolutionize treatments for infectious diseases. His innovative patents and collaborations reflect his commitment to advancing medical science.